Article Text

Download PDFPDF
Acyclovir suppressive therapy after treatment of neonatal herpes

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Neonatal infection with herpes simplex virus (HSV) presents in various ways with varying outcomes. It may be fairly benign with skin, eye and mouth involvement only, no risk of death, and a very low risk of neurological impairment although there may be skin recurrences. Disseminated disease, however, is associated with a 30% mortality and a 20% risk of neurological sequelae among survivors. Central nervous system (CNS) infection is associated with a 6% mortality but a 70% risk of permanent neurological sequelae. The …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.